A Retrospective Clinical Study of 188 Consecutive Patients to Examine the Effectiveness of a Biologically Active Cryopreserved Human Skin Allograft (TheraSkin ®) on the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers

Foot & Ankle Specialist

Volumn 4, Issue 1, 2011, Pages 29-41

  Landsman, Adam Scott ^a   Cook, Jeremy ^b   Cook, Emily ^b   Landsman, Arnold Robert ^c   Garrett, Philip ^d   Yoon, Joonhyun ^d   Kirkwood, Alfred ^d   Desman, Eric ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c Mount Vernon Hospital USA   (United States)

^d Inova Mt Vernon Wound Healing Center   (United States)

Author keywords

comorbid conditions; diabetes; distal wound healing; wound care

Indexed keywords

AGED; ARTICLE; ARTIFICIAL SKIN; CRYOPRESERVATION; DIABETIC FOOT; FEMALE; HUMAN; LEG ULCER; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; RETROSPECTIVE STUDY; WOUND HEALING;

AGED; CRYOPRESERVATION; DIABETIC FOOT; FEMALE; HUMANS; LEG ULCER; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; SKIN, ARTIFICIAL; WOUND HEALING;

EID: 79960957527     PISSN: 19386400     EISSN: None     Source Type: Journal    
DOI: 10.1177/1938640010387417     Document Type: Article

References (21)

1. Sheehan P., Jones P., Caselli A., Giurini JM, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care. 2003; 26: 1879-1882.
2. Boulton AJ, Kirsner RS, Vileikyte L. Clinical practice. Neuropathic diabetic foot ulcers. N Engl J Med. 2004; 352: 48-55.
3. Steed DL, Attinger C., Colaizzi T., et al. Guidelines for the treatment of diabetic ulcers. Wound Repair Regen. 2006; 4: 680-692.
4. Armstrong D., Granick MS, Marston WA, Phillips TJ, Sheehan P. A regimen to optimize the results of a living dermal substitute for healing diabetic foot ulcers. US Endocr Rev. 2007;Spring:60-66.
5. Veves A., Falanga V., Armstrong DG, Sabolinski ML Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multi-center clinical trial. Diabetes Care. 2001; 24: 290-295.
6. Marston WA, Hanft J., Norwood P., Pollak R. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care. 2003; 26: 1701-1705.
7. Kirsner RS, Falanga V. Techniques of split-thickness skin grafting for lower extremity ulcerations. J Dermatol Surg Oncol. 1993; 19: 779-783.
8. Cornwell KG, Landsman A., James KS Extracellular matrix biomaterials for soft tissue repair. Clin Podiatr Med Surg. 2009; 26: 507-523.
9. Eckes B., Nischt R., Krieg T. Cell-matrix interactions in dermal repair and scarring. Fibrogenesis Tissue Repair. 2010; 3: 4.
10. Tran KT, Griffith L., Wells A. Extracellular matrix signaling through growth factor receptors during wound healing. Wound Repair Regen. 2004; 12: 262-268.
11. Lin Q., Rosines E., Clagett J., Taylor BM Independent study funded by Skin and Wound Allograft Institute, a subsidiary of LifeNet Heatlh, Virginia Beach, VA. Study conducted at Albany Medical Center and the University of Maryland, Institute of Human, January 2010.
12. Taylor BM Independent study funded by Skin and Wound Allograft Institute, a subsidiary of LifeNet Heatlh, Virginia Beach, VA. Study conducted at University of Maryland, March 2010.
13. Spence RJ, Wong L. The enhancement of wound healing with human skin allograft. Surg Clin North Am. 1997; 77: 731-745.
14. Margolis DJ, Kantor J., Berlin JA Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis. Diabetes Care. 1999; 22: 692-695.
15. Kantor J., Margolis DJ Treatment options for diabetic neuropathic foot ulcers: a cost-effectiveness analysis. Dermatol Surg. 2001; 27: 347-351.
16. Steinberg JS, Edmonds M., Hurley DP Jr, King WN Confirmatory data from EU study supports Apligraf for the treatment of neuropathic diabetic foot ulcers. J Am Podiatr Med Assoc. 2010; 100: 73-77.
17. Cardinal M., Eisenbud D., Zelen C. Successful healing in a consecutive series of diabetic foot ulcers treated with Dermagraft. Paper presented at: Diabetic Global Foot Conference; March 13-15, 2008.
18. Omar AA, Mavor AID, Jones AM, Homer-Vanniasinkam S. Treatment of venous leg ulcers with Dermagraft. Eur J Vasc Endovasc Surg. 2004; 27: 666-672.
19. Falanga V., Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen. 1999; 7: 201-207.
20. Falanga V., Margolis D., Alvarez O., et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch Dermatol. 1998; 134: 293-300.
21. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005; 355: 1736-1743.